TLS and The Ohio State University Collaborate to Develop Boron Precision Cancer Therapy
In a groundbreaking advancement for precision oncology, TAE Life Sciences (TLS) announced on May 3rd, the signing of a Letter of Intent to collaborate with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) in the development and evaluation of novel boron-based […]
